Author: GlobeNewswire

LA JOLLA, Calif., April 21, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…

VANCOUVER, BC , April 21, 2022 (GLOBE NEWSWIRE) — via InvestorWire — AREV Life Sciences Global Corp. (CSE: AREV) (OTC:…

VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) — via InvestorWire  — AREV Life Sciences Global Corp. (CSE: AREV) (OTC:…

WATERTOWN, Mass., April 21, 2022 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and…

Montrouge, France, April 21, 2022Ordinary and Extraordinary General Meeting of May 12, 2022 Procedures for Obtaining Preparatory Documents for the…

SAN FRANCISCO, April 21, 2022 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a…

HOLLISTON, Mass., April 21, 2022 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first…

LEXINGTON, Mass., April 21, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens…

REDWOOD CITY, Calif., April 21, 2022 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading enzyme engineering company enabling the…

CAMBRIDGE, Mass., April 21, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target…